Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-06-06 @ 5:36 PM
Study NCT ID:
NCT02197650
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2018-12-04
First Post:
2014-05-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase
Sponsor:
ERYtech Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GRASPALL 2012-10-EAP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None